Select Page

Post-Marketing / Real World Evidence / Vaccine

Home » Post-Marketing / Real World Evidence / Vaccine


The use of real-world data is growing rapidly in clinical development. With our in-house capabilities we can help you turn this real-world data into real-world clinical evidence.

Tigermed has established a global service network. Utilizing our trial services helps broaden the scope of our clients’ clinical development and subsequently delivers the most value from their products with the optimal balance of quality, speed and efficiency.


Post-Marketing Study

  • PMS for drug & medical device
  • Intensive Medicines Monitoring / Post-Approval Safety Study
  • Non Interventional prospective study


Read more



Real World Evidence

  • Retrospective study
  • Patient registry
  • Pragmatic clinical trial


Read more



Vaccine Clinical Trials

*As of Q1 2020
  • Clinical research experience in phase I/II/III vaccine registration and post-marketing clinical research;
  • More than 15 cases of large-scale vaccine clinical projects;
  • International partners including Merck, Sanofi Pasteur, etc.


Read more



We have always embraced the latest technology and to be a thought leader in clinical research. For this reason we are known as the Innovative CRO in China.


With a rich background in biometrics and statistical methods, we are well positioned for generating your real-world clinical evidence.